Severe Anemia at Birth-Incidence and Implications.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
09 2022
Historique:
received: 02 02 2022
revised: 17 05 2022
accepted: 27 05 2022
pubmed: 7 6 2022
medline: 21 9 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

To identify neonates with severe anemia at birth, defined by a hemoglobin or hematocrit value within the first 6 hours after birth that plotted below the 1st percentile according to gestational age. For each patient, we retrospectively determined whether caregivers recognized the anemia within the first 24 hours after birth and the probable cause and outcome of anemia. This was a retrospective cohort analysis of Intermountain Healthcare population-based data from neonates born between January 2011 and December 2020 who had a hemoglobin or hematocrit value measured within the first 6 hours after birth below the 1st percentile lower reference interval (hematocrit ∼35% in near-term/term neonates). Among 299 927 live births, we identified 344 neonates with severe anemia at birth. In 191 of these neonates (55.5%), the anemia was recognized by caregivers during the first 24 hours. Anemia was more likely to be recorded as a problem (85%) if the hemoglobin was ≥2 g/dL below the 1st percentile (P < .001). The lowest hemoglobin values occurred in those in whom hemorrhage was the probable cause (P < .013 vs hemolysis and P < .001 vs hypoproduction, mixed cause, or indeterminant.) Treatment was provided to 39.5%. A retrospective review suggested that mixed mechanisms, particularly hemorrhagic plus hemolytic, occurred more commonly than was recognized at the time of occurrence. Severe anemia at birth often went unrecognized on the first day of life. Algorithm-directed retrospective reviews commonly identified causes that were not listed in the medical record. We postulate that earlier recognition and more accurate diagnoses would be facilitated by an electronic medical record-associated hemoglobin/hematocrit gestational age nomogram.

Identifiants

pubmed: 35660494
pii: S0022-3476(22)00516-9
doi: 10.1016/j.jpeds.2022.05.045
pii:
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-45.e2

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Timothy M Bahr (TM)

Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT; Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT. Electronic address: tim.bahr@imail.org.

Shelley M Lawrence (SM)

Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT.

Erick Henry (E)

Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT.

Robin K Ohls (RK)

Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT.

Shihao Li (S)

Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT.

Robert D Christensen (RD)

Obstetric and Neonatal Operations, Intermountain Healthcare, Salt Lake City, UT; Division of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH